John R Chiminski

CIK 1482197 · Executive Chair · last filed 2026-06-02

John R Chiminski is an Executive Chair who has filed 52 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing, for QDEL, was dated Jun 2, 2026. Across all open-market trades the lifetime net is −$96.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $132.1K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$132.1K

Companies

5

Total Filings

52

Lifetime Open-Market Net

-$95.96M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
QDEL Director 9,352 $14.13 $132.1K $0 3 2026-06-02
Bruker Cellular Analysis, Inc. (CELL) Delisted Director 41,240 $1.00 $41.2K $0 2 2023-10-03
Catalent, Inc. (CTLT) Delisted Executive Chair 229,888 $63.48 $14.59M -$96.05M 42 2022-08-26
Bruker Cellular Analysis, Inc. (BLI) Delisted Director 42,465 $1.20 $51.0K $93.3K 3 2022-08-01
Graham Packaging Co Inc. (GRM) Delisted Director $0 2 2011-09-09

Recent Filings

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-06-02 QDEL Mixed +6,829 $0 EDGAR
2025-06-02 QDEL Grant (A) $0 EDGAR
2025-05-27 QDEL Mixed +2,523 $0 EDGAR
2023-10-03 Bruker Cellular Analysis, Inc. (CELL) Delisted Disp (D) −112,465 $0 EDGAR
2023-06-01 Bruker Cellular Analysis, Inc. (CELL) Delisted Grant (A) +70,000 $0 EDGAR
2022-08-26 Catalent, Inc. (CTLT) Delisted Mixed +60,341 -$4.01M EDGAR
2022-08-01 Bruker Cellular Analysis, Inc. (BLI) Delisted Grant (A) +19,565 $0 EDGAR
2022-07-28 Catalent, Inc. (CTLT) Delisted Mixed +27,474 -$1.04M EDGAR
2022-03-15 Bruker Cellular Analysis, Inc. (BLI) Delisted Buy (P) +18,000 $93.3K EDGAR
2021-10-05 Catalent, Inc. (CTLT) Delisted Mixed −76,799 -$16.99M EDGAR
Showing 110 of 52
Page 1 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.